Regulaxis SAS
About:
Regulaxis is focused in research, development and licensing of human innovative synthetic molecules for high unmet medical needs
Website: http://regulaxis.com/
Twitter/X: regulaxis
Top Investors: EASME - EU Executive Agency for SMEs
Description:
Regulaxis mission is to grant licenses of innovative molecules after phase II clinical records.
Total Funding Amount:
3.21M EUR
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Romainville, Ile-de-France, France
Founded Date:
2013-12-01
Contact Email:
regulaxis(AT)regulaxis.com
Founders:
Claude Carelli
Number of Employees:
1-10
Last Funding Date:
2018-07-30
IPO Status:
Private
Industries:
© 2025 bioDAO.ai